IL17A and psoriasis: Multiple inflammatory mediators and signaling pathways contribute to the pathophysiology of psoriasis, including tumor necrosis factor (TNF), prostaglandin–endoperoxide synthase 2 (PTGS2), and interleukin-17A (IL-17A) [4,5,6].